Original CommunicationsPeripheral Arterial Disease: Considerations in Risks, Diagnosis, and Treatment
REFERENCES (57)
- et al.
Prevalence and prognostic influence of peripheral arterial disease in patients ≥ 40 years old admitted into hospital following an acute coronary event
Eur J Vasc Endovasc Surg.
(2008) Peripheral arterial disease
Lancet.
(2001)- et al.
The importance of increasing public and physician awareness of peripheral arterial disease
J Vasc Interv Radiol.
(2002) - et al.
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society forVascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation
J Am Coll Cardiol.
(2006) - et al.
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Am Heart J.
(2004) - et al.
The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease
Am Heart J.
(2004) - et al.
Exercise therapy for claudication
Ann Vasc Surg.
(1999) - et al.
Development of a multicenter peripheral arterial interventional database: the PVD-QI2
Am Heart J.
(2005) Medical treatment of peripheral arterial disease and claudication
N Engl J Med.
(2001)The diagnosis of ischaemic heart pain and intermittent claudication in field surveys
Bull World Health Organ.
(1962)
Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)
J Vasc Surg
(2000)
Classic intermittent claudication is an uncommon manifestation of lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease
Angiology.
(2004)
Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000
Circulation.
(2004)
Determinants of peripheral arterial disease in the elderly: The Rotterdam study
Arch Intern Med.
(2000)
The prevalence of peripheral arterial disease in a defined population
Circulation.
(1985)
Peripheral arterial disease detection, awareness, and treatment in primary care
JAMA.
(2001)
Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004
J Am Geriatr Soc.
(2007)
Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care facility
J Gerontol A Biol Sci Med Sci.
(2002)
Epidemiology and pathophysiology of peripheral arterial disease
Clin Cornerstone.
(2002)
Swiss Atherothrombosis Survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease
J Intern Med.
(2005)
The long-term prognostic value of the resting and postexercise ankle-brachial index
Arch Intern Med.
(2006)
The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease
Vasc Med.
(1998)
Mortality over a period of 10 years in patients with peripheral arterial disease
N Engl J Med.
(1992)
Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review
Circulation.
(1996)
The significance of lower extremity peripheral arterial disease
Clin Cardiol.
(2002)
ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease
BMJ
(2000)
A controlled trial of sustainedrelease bupropion, a nicotine patch, or both for smoking cessation
N Engl J Med.
(1999)
Cited by (0)
Financial Disclosure: Dr Cho has received research grants from Bristol-Myers Squibb/Sanofi-Pharmaceuticals Partnership and has spoken for Medtronic.
Funding/Support: Editorial assistance was funded by Bristol-Myers Squibb/Sanofi-Pharmaceuticals Partnership. The authors did not receive any compensation for this work.
Copyright © 2009 National Medical Association. Published by Elsevier Inc. All rights reserved.